| mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
CEP-701 |
FIMM |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |